Loading patent…
AssigneeAyuvis Research, Inc.
InventorsSuchismita Acharya, Santosh K. Panda, Pragnya Das, Beamon Agarwal
Estimating the term…
The present invention is directed to novel products, variants, pharmaceutically acceptable salts and prodrugs thereof, and medical use of such compounds for the treatment and/or management of sepsis, septicemia, septic shock, ocular infection, ocular inflammation, ocular angiogenesis, rheumatoid arthritis (RA), atherosclerosis, inflammatory bowel diseases (IBD), asthma, chronic obstructive pulmonary disease, fever syndromes, cachexia, psoriasis, autoimmune diseases, cardiac diseases, retinoblastoma, cancer and/or any disorder associated with inflammation, immunomodulation and microbial infection.
A pharmaceutical composition comprising a compound according to Formula (VI), or a pharmaceutically acceptable salt thereof:
A pharmaceutical composition comprising a compound according to Formula (V), or a pharmaceutically acceptable salt thereof:
A composition comprising an effective amount of a compound according to Formula (II), or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.